Pharmacy Times®
Specialty Pharmacy Times
  • Top 10 Trends in Specialty Pharmacy
  • OIG Releases Report on Medicare Part B Drug Price Data
  • Valued Services from Specialty Pharmacy: A Manufacturers Perspective
  • Who Is the Customer in Specialty?
  • How Will Specialty Pharmacy Be Affected By Cost Containment?
  • Specialty Pharmacies Help Patients Manage Immune Globulin Care
More Breast Cancer Patients Choosing Mastectomy
Davy James, Associate Editor
Increased number of patients moving away from breast conservation surgery in early stages of disease.
EPS Releases 3 New Styles of Oral Syringes
Metric-only oral syringes meet ISMP recommendations.
Rheumatoid Arthritis Drug Combination May Slow Disease Progression
Davy James, Associate Editor
First-line therapy with abatacept in combination with methotrexate achieved significantly higher rates of stringent measures of remission in patients with early rheumatoid arthritis.
Cyramza by Eli Lilly
Michael R. Page, PharmD, RPh
Cyramza (ramucirumab) was approved for treatment of patients with advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma after disease progression.
Zontivity by Merck and Co, Inc
Michael R. Page, PharmD, RPh
The FDA has approved Zontivity (voraxapar) for prevention of thrombotic cardiovascular events in patients with peripheral artery disease or a history of myocardial infarction.
Featured Video
Armada and Specialty Pharmacy
Thomas Cohn, chief strategy officer at Armada Health Care, discusses the services Armada provides for specialty pharmacies.
Industry Guide
We've created this Industry Guide with close to 300 companies and organizations as a one-stop guide for industry stakeholders in the specialty pharmacy space.
Current Issue
Conference Calendar
â—„        November 2014        â–º
Featured Company Profile
Pharmacy Times
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Pharmacy Times 2006-2013
Intellisphere, LLC. All Rights Reserved.